Annual Operating Profit
$9.77 B
+$1.82 B+22.94%
31 December 2023
Summary:
Novartis AG annual operaing income is currently $9.77 billion, with the most recent change of +$1.82 billion (+22.94%) on 31 December 2023. During the last 3 years, it has fallen by -$383.00 million (-3.77%). NVS annual operating profit is now -15.24% below its all-time high of $11.53 billion, reached on 31 December 2010.NVS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$3.63 B
-$387.00 M-9.64%
30 September 2024
Summary:
Novartis AG quarterly operating income is currently $3.63 billion, with the most recent change of -$387.00 million (-9.64%) on 30 September 2024. Over the past year, it has increased by +$1.86 billion (+105.85%). NVS quarterly operating profit is now -36.33% below its all-time high of $5.70 billion, reached on 31 March 2000.NVS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$13.60 B
+$1.86 B+15.90%
30 September 2024
Summary:
Novartis AG TTM operating income is currently $13.60 billion, with the most recent change of +$1.86 billion (+15.90%) on 30 September 2024. Over the past year, it has increased by +$4.65 billion (+52.05%). NVS TTM operating profit is now at all-time high.NVS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVS Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.9% | +105.8% | +52.0% |
| 3 y3 years | -3.8% | +12.2% | +15.5% |
| 5 y5 years | +16.3% | +53.8% | +57.6% |
NVS Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -3.8% | +22.9% | -9.6% | +290.4% | at high | +73.5% |
| 5 y | 5 years | -3.8% | +22.9% | -9.6% | +290.4% | at high | +73.5% |
| alltime | all time | -15.2% | +125.9% | -36.3% | +133.0% | at high | +683.5% |
Novartis AG Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.63 B(-9.6%) | $13.60 B(+15.9%) |
| June 2024 | - | $4.01 B(+19.0%) | $11.73 B(+11.5%) |
| Mar 2024 | - | $3.37 B(+30.6%) | $10.52 B(+7.7%) |
| Dec 2023 | $9.77 B(+22.9%) | $2.58 B(+46.5%) | $9.77 B(+9.2%) |
| Sept 2023 | - | $1.76 B(-37.2%) | $8.94 B(-0.7%) |
| June 2023 | - | $2.81 B(+7.2%) | $9.01 B(+6.9%) |
| Mar 2023 | - | $2.62 B(+49.2%) | $8.43 B(-2.7%) |
| Dec 2022 | $7.95 B(-21.0%) | $1.75 B(-3.9%) | $8.66 B(+10.5%) |
| Sept 2022 | - | $1.83 B(-18.0%) | $7.83 B(-15.2%) |
| June 2022 | - | $2.23 B(-21.9%) | $9.24 B(-11.9%) |
| Mar 2022 | - | $2.85 B(+207.0%) | $10.49 B(+4.3%) |
| Dec 2021 | $10.06 B(-0.9%) | $929.00 M(-71.3%) | $10.06 B(-14.6%) |
| Sept 2021 | - | $3.23 B(-7.1%) | $11.77 B(+7.5%) |
| June 2021 | - | $3.48 B(+44.1%) | $10.95 B(+11.5%) |
| Mar 2021 | - | $2.42 B(-8.7%) | $9.82 B(-3.2%) |
| Dec 2020 | $10.15 B(+11.7%) | $2.64 B(+9.6%) | $10.15 B(+8.8%) |
| Sept 2020 | - | $2.41 B(+2.6%) | $9.33 B(+0.6%) |
| June 2020 | - | $2.35 B(-14.3%) | $9.28 B(-3.2%) |
| Mar 2020 | - | $2.74 B(+50.5%) | $9.59 B(+5.5%) |
| Dec 2019 | $9.09 B(+8.1%) | $1.82 B(-22.7%) | $9.09 B(+5.3%) |
| Sept 2019 | - | $2.36 B(-11.5%) | $8.63 B(+1.4%) |
| June 2019 | - | $2.66 B(+18.8%) | $8.51 B(+2.8%) |
| Mar 2019 | - | $2.24 B(+64.6%) | $8.27 B(-1.5%) |
| Dec 2018 | $8.40 B(-3.4%) | $1.36 B(-39.2%) | $8.40 B(-8.5%) |
| Sept 2018 | - | $2.24 B(-7.9%) | $9.18 B(-1.3%) |
| June 2018 | - | $2.43 B(+2.5%) | $9.30 B(+1.7%) |
| Mar 2018 | - | $2.37 B(+10.6%) | $9.15 B(+5.2%) |
| Dec 2017 | $8.70 B(+5.2%) | $2.14 B(-9.1%) | $8.70 B(+8.6%) |
| Sept 2017 | - | $2.36 B(+3.4%) | $8.01 B(+1.1%) |
| June 2017 | - | $2.28 B(+18.6%) | $7.93 B(+2.4%) |
| Mar 2017 | - | $1.92 B(+32.1%) | $7.74 B(-6.4%) |
| Dec 2016 | $8.27 B(-7.9%) | $1.46 B(-35.9%) | $8.27 B(-2.6%) |
| Sept 2016 | - | $2.27 B(+8.4%) | $8.49 B(+0.4%) |
| June 2016 | - | $2.09 B(-14.6%) | $8.46 B(-2.2%) |
| Mar 2016 | - | $2.45 B(+46.2%) | $8.64 B(-3.7%) |
| Dec 2015 | $8.98 B(-19.0%) | $1.68 B(-24.9%) | $8.98 B(-7.0%) |
| Sept 2015 | - | $2.23 B(-2.1%) | $9.65 B(-5.0%) |
| June 2015 | - | $2.28 B(-18.1%) | $10.16 B(-8.2%) |
| Mar 2015 | - | $2.79 B(+18.5%) | $11.06 B(-0.3%) |
| Dec 2014 | $11.09 B(+1.0%) | $2.35 B(-14.2%) | $11.09 B(+0.2%) |
| Sept 2014 | - | $2.74 B(-14.0%) | $11.07 B(+1.7%) |
| June 2014 | - | $3.18 B(+13.1%) | $10.89 B(+1.4%) |
| Mar 2014 | - | $2.81 B(+20.7%) | $10.74 B(-0.7%) |
| Dec 2013 | $10.98 B(-4.6%) | $2.33 B(-8.8%) | $10.82 B(-3.4%) |
| Sept 2013 | - | $2.56 B(-15.7%) | $11.20 B(-3.4%) |
| June 2013 | - | $3.03 B(+4.7%) | $11.59 B(-0.6%) |
| Mar 2013 | - | $2.90 B(+6.7%) | $11.67 B(+1.4%) |
| Dec 2012 | $11.51 B | $2.71 B(-7.9%) | $11.51 B(+16.3%) |
| Sept 2012 | - | $2.95 B(-5.1%) | $9.89 B(-0.0%) |
| June 2012 | - | $3.11 B(+13.6%) | $9.89 B(-2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $2.74 B(+149.0%) | $10.11 B(-6.2%) |
| Dec 2011 | $10.78 B(-6.5%) | $1.10 B(-62.8%) | $10.78 B(-11.3%) |
| Sept 2011 | - | $2.95 B(-11.2%) | $12.15 B(+3.1%) |
| June 2011 | - | $3.32 B(-2.5%) | $11.78 B(+3.2%) |
| Mar 2011 | - | $3.41 B(+38.1%) | $11.42 B(-0.9%) |
| Dec 2010 | $11.53 B(+15.5%) | $2.47 B(-4.6%) | $11.53 B(-1.5%) |
| Sept 2010 | - | $2.59 B(-12.6%) | $11.70 B(-0.4%) |
| June 2010 | - | $2.96 B(-15.7%) | $11.74 B(+5.4%) |
| Mar 2010 | - | $3.51 B(+33.1%) | $11.15 B(+14.2%) |
| Dec 2009 | $9.98 B(+11.4%) | $2.64 B(+0.1%) | $9.76 B(+10.9%) |
| Sept 2009 | - | $2.63 B(+11.4%) | $8.80 B(+3.5%) |
| June 2009 | - | $2.36 B(+11.3%) | $8.50 B(-1.1%) |
| Mar 2009 | - | $2.12 B(+26.4%) | $8.60 B(-4.1%) |
| Dec 2008 | $8.96 B(+32.2%) | $1.68 B(-28.1%) | $8.96 B(+18.1%) |
| Sept 2008 | - | $2.33 B(-5.1%) | $7.59 B(+4.0%) |
| June 2008 | - | $2.46 B(-1.1%) | $7.30 B(+6.0%) |
| Mar 2008 | - | $2.49 B(+710.4%) | $6.88 B(+2.3%) |
| Dec 2007 | $6.78 B(-11.3%) | $307.00 M(-85.0%) | $6.73 B(-17.4%) |
| Sept 2007 | - | $2.04 B(-0.1%) | $8.15 B(+0.8%) |
| June 2007 | - | $2.04 B(-12.4%) | $8.08 B(-0.2%) |
| Mar 2007 | - | $2.33 B(+35.4%) | $8.10 B(+3.5%) |
| Dec 2006 | $7.64 B(+17.4%) | $1.73 B(-12.8%) | $7.83 B(+8.8%) |
| Sept 2006 | - | $1.98 B(-4.2%) | $7.19 B(+1.3%) |
| June 2006 | - | $2.06 B(+0.3%) | $7.10 B(+3.1%) |
| Mar 2006 | - | $2.06 B(+88.8%) | $6.88 B(+5.8%) |
| Dec 2005 | $6.51 B(+6.4%) | $1.09 B(-42.3%) | $6.51 B(-0.3%) |
| Sept 2005 | - | $1.89 B(+2.1%) | $6.53 B(+2.7%) |
| June 2005 | - | $1.85 B(+10.1%) | $6.36 B(+0.9%) |
| Mar 2005 | - | $1.68 B(+51.1%) | $6.30 B(+3.0%) |
| Dec 2004 | $6.12 B(+8.6%) | $1.11 B(-35.2%) | $6.12 B(-3.8%) |
| Sept 2004 | - | $1.72 B(-4.3%) | $6.36 B(+4.1%) |
| June 2004 | - | $1.79 B(+20.1%) | $6.11 B(+5.7%) |
| Mar 2004 | - | $1.49 B(+10.5%) | $5.78 B(+2.5%) |
| Dec 2003 | $5.63 B(+10.7%) | $1.35 B(-8.0%) | $5.63 B(+0.1%) |
| Sept 2003 | - | $1.47 B(+0.4%) | $5.63 B(+4.2%) |
| June 2003 | - | $1.46 B(+8.3%) | $5.40 B(+0.4%) |
| Mar 2003 | - | $1.35 B(+0.4%) | $5.38 B(-39.5%) |
| Dec 2002 | $5.09 B(+17.7%) | $1.35 B(+8.4%) | $8.89 B(-481.5%) |
| Sept 2002 | - | $1.24 B(-13.9%) | -$2.33 B(-216.3%) |
| June 2002 | - | $1.44 B(-70.3%) | $2.00 B(+30.7%) |
| Mar 2002 | - | $4.86 B(-149.2%) | $1.53 B(+37.5%) |
| Dec 2001 | $4.33 B(-11.4%) | -$9.87 B(-277.0%) | $1.11 B(>+9900.0%) |
| Sept 2001 | - | $5.58 B(+474.3%) | $0.00(-100.0%) |
| June 2001 | - | $971.00 M(-78.1%) | -$695.00 M(+4.4%) |
| Mar 2001 | - | $4.44 B(-140.4%) | -$666.00 M(-212.7%) |
| Dec 2000 | $4.88 B(+5.9%) | -$10.99 B(-325.1%) | $591.00 M(-94.9%) |
| Sept 2000 | - | $4.88 B(+388.1%) | $11.58 B(+72.9%) |
| June 2000 | - | $1.00 B(-82.4%) | $6.70 B(+17.6%) |
| Mar 2000 | - | $5.70 B | $5.70 B |
| Dec 1999 | $4.61 B(-8.3%) | - | - |
| Dec 1998 | $5.03 B | - | - |
FAQ
- What is Novartis AG annual operaing income?
- What is the all time high annual operating profit for Novartis AG?
- What is Novartis AG annual operating profit year-on-year change?
- What is Novartis AG quarterly operating income?
- What is the all time high quarterly operating profit for Novartis AG?
- What is Novartis AG quarterly operating profit year-on-year change?
- What is Novartis AG TTM operating income?
- What is the all time high TTM operating profit for Novartis AG?
- What is Novartis AG TTM operating profit year-on-year change?
What is Novartis AG annual operaing income?
The current annual operating profit of NVS is $9.77 B
What is the all time high annual operating profit for Novartis AG?
Novartis AG all-time high annual operaing income is $11.53 B
What is Novartis AG annual operating profit year-on-year change?
Over the past year, NVS annual operaing income has changed by +$1.82 B (+22.94%)
What is Novartis AG quarterly operating income?
The current quarterly operating profit of NVS is $3.63 B
What is the all time high quarterly operating profit for Novartis AG?
Novartis AG all-time high quarterly operating income is $5.70 B
What is Novartis AG quarterly operating profit year-on-year change?
Over the past year, NVS quarterly operating income has changed by +$1.86 B (+105.85%)
What is Novartis AG TTM operating income?
The current TTM operating profit of NVS is $13.60 B
What is the all time high TTM operating profit for Novartis AG?
Novartis AG all-time high TTM operating income is $13.60 B
What is Novartis AG TTM operating profit year-on-year change?
Over the past year, NVS TTM operating income has changed by +$4.65 B (+52.05%)